Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan-Lu Liu

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
European Journal of Medicinal Chemistry|April 19, 2023
Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19Fatema Hersi, Anusha Sebastian, Hamadeh Tarazi, et al.
Nature Chemical Biology|July 25, 2022
Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infectionZhifen Cui, Cong Zeng, Furong Huang, et al.
Journal of Virology|May 20, 2024
S309-CAR-NK cells bind the Omicron variants <i>in vitro</i> and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG miceMinh Tuyet Ma, Qingkui Jiang, Chih-Hsiung Chen, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Neutralization and Stability of SARS-CoV-2 Omicron VariantCong Zeng, John P Evans, Panke Qu, et al.
Nature Communications|August 5, 2018
A Zika virus vaccine expressing premembrane-envelope-NS1 polyproteinAnzhong Li, Jingyou Yu, Mijia Lu, et al.
Cell Host & Microbe|December 8, 2022
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2Panke Qu, John P Evans, Julia N Faraone, et al.
Nature Microbiology|January 31, 2018
Structural basis for neutralization of Japanese encephalitis virus by two potent therapeutic antibodiesXiaodi Qiu, Yingfeng Lei, Pan Yang, et al.
Cell Host & Microbe|May 8, 2022
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2John P Evans, Cong Zeng, Panke Qu, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell FusionPei Li, Yajie Liu, Julia Faraone, et al.
Cell Reports|April 27, 2023
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variantsPanke Qu, Julia N Faraone, John P Evans, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
European Journal of Medicinal Chemistry|April 19, 2023
Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19Fatema Hersi, Anusha Sebastian, Hamadeh Tarazi, et al.
Nature Chemical Biology|July 25, 2022
Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infectionZhifen Cui, Cong Zeng, Furong Huang, et al.
Journal of Virology|May 20, 2024
S309-CAR-NK cells bind the Omicron variants <i>in vitro</i> and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG miceMinh Tuyet Ma, Qingkui Jiang, Chih-Hsiung Chen, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Neutralization and Stability of SARS-CoV-2 Omicron VariantCong Zeng, John P Evans, Panke Qu, et al.
Nature Communications|August 5, 2018
A Zika virus vaccine expressing premembrane-envelope-NS1 polyproteinAnzhong Li, Jingyou Yu, Mijia Lu, et al.
Cell Host & Microbe|December 8, 2022
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2Panke Qu, John P Evans, Julia N Faraone, et al.
Nature Microbiology|January 31, 2018
Structural basis for neutralization of Japanese encephalitis virus by two potent therapeutic antibodiesXiaodi Qiu, Yingfeng Lei, Pan Yang, et al.
Cell Host & Microbe|May 8, 2022
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2John P Evans, Cong Zeng, Panke Qu, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell FusionPei Li, Yajie Liu, Julia Faraone, et al.
Cell Reports|April 27, 2023
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variantsPanke Qu, Julia N Faraone, John P Evans, et al.
Pageof 14